Orthofix Medical (OFIX) Shares Outstanding (Weighted Average) (2009 - 2026)

Orthofix Medical has disclosed Shares Outstanding (Weighted Average) across 18 years of filings, most recently posting $40.4 million for Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 3.22% year-over-year to $40.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.4 million (up 3.22% YoY) and the FY2025 annual result came in at $39.6 million, up 3.85% from the prior year.
• Shares Outstanding (Weighted Average) improved to $40.4 million in Q1 2026, from $39.6 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $40.4 million in Q1 2026 and troughed at $19898.0 in Q1 2022.
• A 5-year average of $26.2 million and a median of $37.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) tumbled 99.9% — and 2023, when it soared 186079.84%.
• Tracing OFIX's Shares Outstanding (Weighted Average) over 5 years: stood at $20.1 million in 2022, then jumped by 83.16% to $36.7 million in 2023, then climbed by 3.82% to $38.1 million in 2024, then increased by 3.85% to $39.6 million in 2025, then grew by 2.14% to $40.4 million in 2026.
• Business Quant data shows OFIX's Shares Outstanding (Weighted Average) at $40.4 million in Q1 2026, $39.6 million in Q4 2025, and $39.8 million in Q3 2025.